Elucidating the exact pharmacological mechanism of motion (MOA) of naturally happening compounds can be challenging. Despite the fact that Tarselli et al. (60) created the first de novo artificial pathway to conolidine and showcased this naturally happening compound effectively suppresses responses to both chemically induced and inflammation-derived pain, the https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers